Pretty horrific if true.
What’s most interesting to me is that for the 25-34 yo age group we see very little change from 2002 to 2014 in either the Black or Hispanic rates. They trend up & down and back up, but across a narrow range. Meanwhile it’s a pretty fair bet their incidence of actual real pain hasn’t changed much over that time interval, nor has their incidence of all-flavors drug abuse.
So the docs aren’t prescribing more opioids for that population and that population isn’t taking more opioids whether illicit or legit.
At the same time over in Whiteyville the opioid overdoses have gone up ~2.5x. Again, as with the other ethnic groups, the incidence of real pain is almost certainly unchanged.
What *has *changed, and changed bigtime, is some combo of doc’s prescribing habits and white folks’ drug seeking behavior.
This leads me to the soft conclusion that black, brown, and white legit pain is controlled about as well or as badly as it ever was. There’s no way to tease more about that issue from the facts provided. Note I’m not saying it’s treated equally well between the three groups. Just that each group’s experience hasn’t changed.
But clearly a huge new arena has opened for white drug seeking behavior funneling legit opioid meds via docs into abusers. An avenue which the other groups either are not pursuing, or are effectively locked out of.
The article has no objective info about other changes in Black and Hispanic drug consumption or overdose experience. It may simply be fashion that, say, Hispanics prefer heroin & Blacks prefer cocaine, whereas Whitey likes prescription opioids.
ISTR reading some legit scholarly work on this a couple years ago that something like 2% of physicians were writing like 90% of the scripts for opioids. IOW, licensed pain clinics that were really just wholesalers to networks of small-time drug pushers. It was this discovery that really put a bee in the FDA’s bonnet to clamp down on rogue prescribers and sloppy pharmacy ops.
It would be interesting to update this article with data from 2015 when the FDA’s changes have had time to take effect.